Specialty Genetic Testing CPT.xlsx
XLSX spreadsheet 27 KB Posted
- Solicitation number
- 36C25721Q0294
About this file
This document combines a solicitation for specialty genetic reference laboratory testing services with a related federal contract opportunity notice. The solicitation requests quotes for specialty genetic testing services listed in an attached CPT code sheet. Required services include flow cytometry, cytogenetics, fluorescence in situ hybridization (FISH), anatomic pathology, molecular pathology, and liquid biopsy tests. Quotes are due by January 14, 2021 for services for the South Texas Veterans Healthcare System Laboratory. The opportunity notice provides additional context, specifying this is solicitation number 36C25721Q0294 from the Department of Veterans Affairs Veterans Health Administration VISN 17 for a one year contract with option years to provide the referenced testing services. Evaluation criteria, solicitation provisions and clauses, and additional terms are provided.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Wage Determination 15-5253.pdf | ||
| 36C25721Q0294_1.docx | DOCX document | |
| 36C25721Q0294.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| Estimated Annual Quantities (Base Year) - A | |||||
| REF | Test Name | CPTS | Estimated Quanity | Self-Perform (in-house)? | |
| Yes / No | Name of Lab Performing Test | CLIA Certificate Number of Lab Performing Test | Amount | ||
| 10 Color Flow Cytometry | |||||
| AA | Technical Component Up to 24 markers | 88184, 88185 | 10 | ||
| AB | Additional Marker >24 (per Markers) | 88185 | 10 | ||
| AC | Flow Interpretation | 88187, 88188, 88189 | 10 | ||
| 10 Color Flow Cytometry Special Pricing | |||||
| AD | Flow Profile PNH Tech(8) | 88184, 88185 | 10 | ||
| AF | Flow Profile DNA Global | 88182 | 10 | ||
| AE | Special Flow Profiles | No CPTs available | 10 | ||
| CYTOGENETICS | |||||
| AF | Chromosome Analysis | 88237 or 88233 or 88230 or 88235 or 88239, +88261 or 88262 or 88264, +88280, +88285 | 35 | ||
| AG | Additional Karyotypes | 88280 | 35 | ||
| AH | Additional Cells | 88285 | 35 | ||
| AI | Additional Culture | 88237 or 88239 | 35 | ||
| AJ | No Growth | No CPT Code | 35 | ||
| AK | Chromosome Analysis Interpretation | 88291 | 35 | ||
| FISH | |||||
| AL | FISH Manual-Tech only (Initial Single Probe Staining Procedure) | 88368TC | 350 | ||
| AM | FISH Manual-Interpretation(Initial Single Probe Staining Procedure) | 88368PC | 350 | ||
| AN | FISH Manual-Global(Initial Single Probe Staining Procedure) | 88368 | 350 | ||
| AO | |||||
| AP | FISH Manual- Tech only (Additional Single Probe Staining Procedure) | 88369TC | 5 | ||
| AQ | FISH Manual-Interpretation(Additional Single Probe Staining Procedure) | 88369PC | 5 | ||
| AR | FISH Manual-Global(Additional Single Probe Staining Procedure) | 88369 | 5 | ||
| AS | |||||
| AT | FISH Manual-Tech only (Each Multiplex Probe Staining Procedure) | 88377TC | 5 | ||
| AU | FISH Manual-Interpretation(Each Multiplex Probe Staining Procedure) | 88377PC | 5 | ||
| AV | FISH Manual-Global(Each Multiplex Probe Staining Procedure) | 88377 | 5 | ||
| AW | |||||
| FISH Automated-Tech (Initial Single Probe Staining Procedure) | 88367TC | 5 | |||
| AZ | FISH Automated-Interpretation(Initial Single Probe Staining Procedure) | 88367PC | 5 | ||
| AY | FISH Automated-Global(Initial Single Probe Staining Procedure) | 88367 | 5 | ||
| AZ | |||||
| FISH Automated-Tech only (Additional Single Probe Staining Procedure) | 88373TC | 5 | |||
| BA | FISH Automated-Interpretation(Additional Single Probe Staining Procedure) | 88373PC | 5 | ||
| BB | FISH Automated-Global(Additional Single Probe Staining Procedure) | 88373 | 5 |
| BC | FISH Automated-Tech only (Each Multiplex Probe Staining Procedure) | 88374TC | 5 |
| BD | FISH Automated-Interpretation(Each Multiplex Probe Staining Procedure) | 88374PC | 5 |
| BE | FISH Automated-Global(Each Multiplex Probe Staining Procedure) | 88374 | 5 |
| BF | |||
| Manual Bladder, Cancer FISH | |||
| Bladder Cancer FISH Tech(4 probes)-Manual Read | 882120TC | 5 | |
| BG | Bladder Cancer FISH Interpretation(4 probes)-Manual Read | 88120PC | 5 |
| BH | Bladder Cancer FISH Global(4 probes)-Manual Read | 88120 | 5 |
| Automated Bladder, Cancer FISH | |||
| BI | Bladder Cancer FISH Tech(4 probes)-Auto Read | 88121TC | 5 |
| BJ | Bladder Cancer FISH Interpretation(4 probes)-Auto Read | 88121PC | 5 |
| BK | Bladder Cancer FISH Global(4 probes)-Auto Read | 88121 | 5 |
| Anatomic Pathology | |||
| BL | Blood Smear Interpretation | 85060 | 5 |
| BM | Bone Marrow Interpretation | 85097 | 5 |
| BP | Surgical Pathology | 88305 | 5 |
| BQ | Surgical Pathology Tech | 88305TC | 5 |
| BR | Decalcification | 88311 | 5 |
| BS | Decalcification Tech | 88311TC | 5 |
| BT | Special Stain | 88312 | 5 |
| BU | Special Stain Tech | 88312TC | 5 |
| BV | Tissue Special Stain | 88313 | 5 |
| BW | Tissue Special Stain Tech | 88313TC | 5 |
| BX | Histo/Cytochemistry to ID Enzyme | 88314 | 5 |
| BY | Histo/Cytochemistry to ID Enzyme Tech | 88314TC | 5 |
| BZ | Cytochemistry | 88319 | 5 |
| CA | Cytochemistry Tech | 88319TC | 5 |
| CB | Consult | 88321 | 5 |
| CC | Professional Consult | 88323 | 5 |
| CD | Professional Consult Tech | 88323TC | 5 |
| CE | Comprehensive Consult | 88325 | 5 |
| CF | IHC Qualitative;addn'l stain procedure | 88341 | 5 |
| CG | IHC Qualitative;addn'l stain procedure Tech | 88341TC | 5 |
| CH | IHC Qualitative; per specimen; Initial Single antibody strain | 88342 | 400 |
| CI | IHC Qualitative; per specimen; Initial Single antibody strain tech | 88342TC | 400 |
| CJ | IHC Qualitative; per specimen; multiplex antibody stain | 88344 | 400 |
| CK | IHC Qualitative; per specimen; multiplex antibody stain tech | 88344TC | 400 |
| CL | PD-L1(KEYTRUDA, OPDIVO, TECENTRIZ, Glo | 88360 | 50 |
| CM | PD-L1(KEYTRUDA, OPDIVO, TECENTRIZ, Tech | 88360TC | 50 |
| CN | IHC Quantitative | 88360 | 10 |
| CO | IHC Quantitative tech | 88360TC | 10 |
| CP | IHC Morphometric Analysis; computer assist, Glo | 88361 | 10 |
| CQ | IHC Morphometric Analysis; computer assist, Tech | 88361TC | 10 |
| CR | Cytopathology, Selective Cellular Enhancement, Global | 88112 | 10 |
| CS | Cytopathology, Selective Cellular Enhancement | 88112TC | 10 |
| CT | IHC by ISH | 88365/ 88364 | 10 |
| CU | IHC by ISH TC | 88365TC/ 88364TC | 10 |
| CV | HPV ISH | 88365/ 88364 | 10 |
| CW | HPV ISH, Tech | 88365TC/ 88364TC | 10 |
| Molecular Pathology | |||
| CX | ABL Kinase Domain Mutation Analysis(Bi-directional Sequencing) | 81170 | 5 |
| CY | Androgen Receptor Mutation Analysis | 81204 | 5 |
| CZ | ALL Fusion Profile | 81450 | 5 |
| ALK Mutation Analysis | 81479 | 5 | |
| Db | ASXL1 Mutation Analysis | 81175 | 5 |
| DB | ATRX Mutation Analysis | 81479 | 5 |
| DC | BCR-ABL1 Standard p210, p190 | 81479 | 300 |
| DD | Quantitative BCR/ABL, t(9:22) Major(p210) for CML | 81206 | 5 |
| DE | Quantitative BCR/ABL, t(9:22) Minor(p210) for ALL | 81207 | 5 |
| DF | BCR ABL1 Non Standard p230 | 81208 | 300 |
| DG | B-Cell Gene Rearrangement(Fragment Length Analysis) | 81479 | 30 |
| DH | B-Cell Gene Rearrangement-IGH | 81261 | 30 |
| DI | B-Cell Gene Rearrangement-IGK | 81264 | 30 |
| DJ | T-Cell Receptor Beta Gene Rearrangement | 81340 | 25 |
| DK | T-Cell Receptor Gamma Gene Rearrangement | 81342 | 25 |
| DL | B&T Cell Gene Rearrangement(Fragment Length Analysis) | 81479 | 5 |
| DM | B-Cell Gene Rearrangement IGH | 81261 | 5 |
| DN | B-Cell Gene Rearrangement-IGK | 81264 | 5 |
| DO | T-Cell Receptor Gamma Gene Rearrangement | 81342 | 5 |
| DP | BCL-1 Translocation t(11:14) | 81401 | 5 |
| DQ | BCL-2 Translocation t(14:18) | 81401 | 5 |
| DR | BRCA1/2 Mutation &Del/Dup Analysis | 81162 | 5 |
| BRCA1/2 Mutation Analysis for Tumors | 81163 | ||
| DS | BRCA 1 Mutation & Del/Dup Analysis | 81166 | 5 |
| DT | BRCA 2 Mutation & Del/Dup Analysis | 81167 | 5 |
| DU | BRAF Mutation Analysis(Bi-directional Sequencing) | 81210 | 25 |
| THxID BRAF Mutation Analysis by PCR for Melanoma | 81210 | 25 | |
| DV | KRAS Mutation Analysis(Bi-Directional Sequencing) | 81275 | 25 |
| DX | BTK Mutation Analysis(Single Gene Assay) | 81233 | 5 |
| DY | BTK Inhibitor Acquired Resistance Panel | 81479 | 5 |
| DZ | BTK Inhibitor Primary Susceptibility Panel | 81479 | 5 |
| EA | CALR Mutation Analysis | 81219 | 5 |
| EB | CARD11 Mutation Analysis | 81479 | 5 |
| EE | CEBPA Mutation Analysis(Bi-directional Sequencing) | 81218 | 5 |
| EF | KIT(c-KIT) Mutation Analysis | 81272 | 5 |
| EH | CSF3R Mutation Analysis | 81479 | 5 |
| EI | CX CR4 Mutation Analysis (Bi-directional Sequencing) | 81479 | 5 |
| DNA Fingerprinting Analysis | 81265 or 81266 | 5 | |
| EJ | DNMT3A Mutation Analysis (Bi-directional Sequencing) | 81403 | 5 |
| EK | EGFR Mutation Analysis(Bi-directional Sequencing) | 81235 | 20 |
| EL | EGFR VIII Analysis | 81479 | 5 |
| EM | EGFR T790M Germline Mutation Analysis | 81235 | 5 |
| EP | ETV6-RUNX1 (TEL-AML1) Translocation, t(12;21) | 81401 | 5 |
| FGFR CDx Molecular Analysis by PCR | 0154U | 25 | |
| ER | FLT3 (ITD & TKD) Mutation Analysis | 81479 | 5 |
| ES | FLT3 (incl D385)Mutation Analysis(Bi-directional Seq & Fragment Length) | 81245 | 5 |
| ET | FLT3 (incl D385)Mutation Analysis(Bi-directional Seq & Fragment Length) | 81246 | 5 |
| EV | Hereditary Cancer Comprehensive Panel | 81432 | 5 |
| EZ | HPV DNA Tissue Testing | 87624 | 5 |
| FA | HRAS Mutation Analysis(Bi-directional Sequencing) | 81403 | 5 |
| FC | IDH1 and IDH2 Mutations Analysis(Bi-directional Sequencing) | 81479 | 5 |
| FD | IgH Clonality/MRD by NGS | 81263 | 5 |
| FE | IgVH Mutation Analysis | 81263 | 5 |
| FG | inv(16) CVFB-MYH11 Translocation | 81401 | 5 |
| InVisionFirst - Lung Liquid Biopsy | 81479 | 10 | |
| FH | JAK2 V617F Mutation Analysis | 81270 | 125 |
| FI | JAK2 Exon 12-14 Mutation Analysis (Bi-directional Seq) | 81403 | 5 |
| FJ | JAK2 V617F with reflex to Exon 12-14 Mutation Analysis (Bi-directional Seq) | 81270, 81403 | 5 |
| FK | Lynch Syndrome (include EPCAM, MLH1, MSH2, MSH6, PMS2) | 81445 | 5 |
| MAP2K1 Mutation Analysis | 81406 | 5 | |
| FL | MET Exon 14 Deletion Analysis | 81479 | 5 |
| FM | MGMT Promoter Methylation Analysis | 81287 | 5 |
| FN | Microsatellite Instability Analysis(Fragment Length Analysis) | 81301 | 15 |
| FP | MLH1 Promoter Methylation Analysis | 81288 | 5 |
| MLL-PTD Analysis | 81479 | 5 | |
| FQ | MPL Mutation Analysis (Bi-directional Sequencing) | 81402 | 5 |
| FU | MPL Mutation Analysis(Bi-directional Sequencing) | 81402 | 20 |
| FV | MPN Extended Reflex Panel | 81479 | 95 |
| FW | JAK2 Exon 12-14 Mutation Analysis (Bi-directional Seq) | 81403 | 5 |
| FX | JAK2 V617F Mutation Analysis | 81270 | 125 |
| FY | CALR Mutation Analysis | 81219 | 95 |
| GB | MYD88 Mutation Analysis | 81479 | 5 |
| Lung NGS Fusion Profile | 81445 | 10 | |
| NexCouse Complete | 81455 | 5 | |
| GE | NGS Comprehensive Sarcoma Fusion Profile | 81479 | 5 |
| GF | NGS Ewing Sarcoma Fusion Profile | 81479 | 5 |
| GG | NGS Non-Ewing Sarcoma Fusion Profile | 81479 | 5 |
| GH | NGS Pediatric Sarcoma Fusion Profile | 81479 | 5 |
| GI | NGS Rhabdomyosarcoma Fusion Profile | 81479 | 5 |
| NTRK NGS Fusion Profile | 81479 | 5 | |
| NTRK & RET NGS Fusion Profile | 81479 | 5 | |
| GK | NOTCH1 Mutation Analysis | 81407 | 5 |
| GL | NPM1 MRD Analysis (Fragment Length Analysis) | 81310 | 5 |
| GM | NRAS Mutation Analysis | 81310 | 25 |
| GN | PDGFRa Mutation Analysis | 81314 | 25 |
| GO | PIK3CA Mutation Analysis (bi-Directional sequencing) | 81314 | 5 |
| GP | PLC-Gamma-2 Mutation Analysis | 81320 | 5 |
| GQ | PML-RARA Translocation, t(15;17) | 81315 | 10 |
| Prosigna Breast Cancer Prognostic Gene Signature | 81520 | 5 | |
| Rapid AML Therapeutic Panel | 81479 | 5 | |
| GW | RAS/RAF Panel | 81479 | 5 |
| GZ | RUNX1-RUNX1T1 (AML1-ETO)Translocation, t(8;21) | 81401 | 5 |
| HB | SF3B1 Mutation Analysis (Bi-Directional Sequencing) | 81479 | 5 |
| HC | SRSF2 Mutation Analysis( Bi-Directional Sequencing) | 81479 | 5 |
| HD | STAT3 Mutation Analysis | 81405 | 5 |
| HE | TERT Promoter Mutation Analysis | 81345 | 5 |
| HF | TET2 Mutation Analysis | 81479 | 5 |
| HG | TP53 Mutation Analysis | 81405 | 10 |
| HK | UGT1A1 Genotyping | 81350 | 5 |
| NEOTYPE(Molecular) | |||
| Hematologic | |||
| HO | NeoType AITL/Peripheral T-Cell Lymphoma Profile | 81479 | 10 |
| HQ | NeoType AML Prognostic Profile | 81450 | 20 |
| HR | NeoType CLL Prognostic Profile | 81479 | 10 |
| HS | NeoType JMML Profile | 81450 | 10 |
| HT | NeoType Lymphoma Profile | 81450 | 10 |
| HU | NeoType MDS/CMML Profile | 81450 | 10 |
| HW | NeoType Myeloid Disorders Profile | 81450 | 10 |
| Solid Tumor Profiles | |||
| HX | NeoType Brain Tumor Profile | 81479 | 2 |
| HY | NeoType Breast Tumor Profile | 81445 | 5 |
| HZ | NeoType Cervical Tumor Profile | 81479 | 5 |
| IA | NeoType Colorectal Tumor Profile | 81445 | 5 |
| IB | NeoType Endometrial Tumor Profile | 81479 | 5 |
| IC | NeoType Esophageal Tumor Profile | 81445 | 5 |
| ID | NEoType Gastric Tumor Profile | 81445 | 5 |
| IE | NeoType GI Predictive Profile | 81479 | 5 |
| IF | NeoType GIST/Soft Tissue Profile | 81479 | 5 |
| IG | NeoType Head & Neck Tumor Profile | 81479 | 5 |
| NeoType HRD+Profile | 81445 | 5 | |
| IH | NeoType Liposarcoma Fusion Profile | 81479 | 5 |
| II | NeoType Liver/Biliary Tumor Profile | 81479 | 5 |
| IJ | NEoType Lung Tumor Profile | 81479 | 5 |
| IK | NeoType Melanoma | 81479 | 5 |
| IL | NeoType Other Solid Tumor Profile | 81479 | 5 |
| IM | NeoType Ovarian Tumor Profile | 81479 | 5 |
| IN | NeoType Pancreas Tumor Profile | 81479 | 5 |
| IP | NeoType Precision Profile for Solid Tumor | 81479 | 5 |
| IQ | NeoType Thyroid Profile | 81479 | 5 |
| NeoTYpe Discovery Profile For Solid Tumors | 81479 | 5 | |
| IR | NeoArray SNP/Cytogenetic Profile | 81229 | 5 |
| NeoType (Global) | |||
| Hematologic Profiles | |||
| IT | NeoType AITL/Peripheral T-Cell Lymphoma Profile | 81479 | 5 |
| NeoType AML Prognostic Profile | 81450 | 5 | |
| IV | NeoType CLL Prognostic Profile | 81479, 88374x4 | 5 |
| IW | NeoType JMML Profile | 81450 | 5 |
| IX | NeoType Lymphoma Profile | 81450 | 5 |
| IY | NeoType MDS/CMML Profile | 81450 | 5 |
| JA | NeoType Myeloid Disorders Profile | 81450 | 5 |
| Solid Tumor Profiles | |||
| JB | NeoType Brain Tumor Profile | 81479, 88377x6, 88360 | 2 |
| JC | NeoType Breast Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JD | NeoType Cervical Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JE | NeoType Colorectal Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JF | NeoType Endometrial Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JG | NeoType Esophageal Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JH | NEoType Gastric Tumor Profile | 81479, 88377x2, 88342 | 5 |
| JI | NeoType GI Predictive Profile | 81479, 88374, 88360, 88342 | 5 |
| JJ | NeoType GIST / Soft Tissue Profile | 81479, 88377x2, 88360 | 5 |
| JK | NeoType Head & Neck Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JL | NeoType Liposarcoma Fusion Profile | 81479, 88374 OR 88377, 88342 | 5 |
| JM | NeoType Liver/Biliary Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JN | NEoType Lung Tumor Profile | 81479, 88374, 88377x5, 88360, 88342 | 5 |
| JO | NeoType Melanoma Profile | 81479, 88377, 88360, 88342 | 5 |
| JP | NeoType Other Solid Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JQ | NeoType Ovarian Tumor Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JR | NeoType Pancreas Tumor Profile | 81479, 88377x3, 88360, 88342 | 5 |
| JT | NeoType Precision Profile for Solid Tumor | 81479, 88360, 88342 | 5 |
| JU | NeoType Thyroid Profile | 81479, 88377x2, 88360, 88342 | 5 |
| JV | NeoTYpe Discovery Profile For Solid Tumors | 81479, 88374, 88377x8, 88360, 88342 | 5 |
| JW | NeoArray SNP/Cytogenetic Profile | 81229 | 5 |
| NeoType Technical Only | |||
| Hematologic Profiles | |||
| JY | NeoType AITL/Peripheral T-Cell Lymphoma Profile | 81479 | 5 |
| KA | NeoType AML Prognostic Profile | 81450 | 5 |
| KB | NeoType CLL Prognostic Profile | 81479, 88374TC | 5 |
| KC | NeoType JMML Profile | 81450 | 5 |
| KD | NeoType Lymphoma Profile | 81450 | 5 |
| KE | NeoType MDS/CMML Profile | 81450 | 5 |
| KG | NeoType Myeloid Disorders Profile | 81450 | 5 |
| Solid Tumor Profiles | |||
| KH | NeoType Brain Tumor Profile | 81479, 88377TCx7, 88360TC | 5 |
| KI | NeoType Breast Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KJ | NeoType Cervical Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KK | NeoType Colorectal Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KL | NeoType Endometrial Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KM | NeoType Esophageal Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KN | NeoType Gastric Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KO | NeoType GI Predictive Profile | 81479, 88374TC, 88360TC, 88342TC | 5 |
| KP | NeoType GIST/ Soft Tissue Profile | 81479,88377TCx2,88360TC | 5 |
| KQ | NeoType Head & Neck Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KR | NeoType Liposarcoma Fusion Profile | 81479, 88374TC OR 88377TC, 88342TC | 5 |
| KS | NeoType Liver/Biliary Tumor Profile | 81479, 88377TCx2, 88360TC, 88342TC | 5 |
| KT | NEoType Lung Tumor Profile | 81479,88374TC,88377TCX5,88360TC,88342TC | 5 |
| KU | NeoType Melanoma Profile | 81479, 88377TC, 88360TC, 88342TC | 5 |
| KV | NeoType Other Solid Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KW | NeoType Ovarian Tumor Profile | 81479, 88377TCX2, 88360TC, 88342TC | 5 |
| KX | NeoType Pancreas Tumor Profile | 81479, 88377TCX3, 88360TC, 88342TC | 5 |
| KZ | NeoType Precision Profile for Solid Tumor | 81479, 88360TC, 88342TC | 5 |
| LA | NeoType Thyroid Profile | 81479, 88377TCx2, 88360TC, 88342TC | 5 |
| LB | NeoTYpe Discovery Profile For Solid Tumors | 81479, 88374TC, 88377TCx8, 88360TC, 88342TC | 5 |
| LC | NeoArray SNP/Cytogenetic Profile | 81229 | 5 |
| NeoLAB Liquid Biopsy | |||
| LE | NeoLab AML-Profile Liquid Biopsy | 81450 | 5 |
| LF | NeoLab BTK Inhibitor Acquired Resistance Panel Liquid Biopsy | 81479 | 5 |
| LG | NeoLab c-kit Mutation Analysis-Liquid Biopsy | 81272 | 5 |
| LH | NeoLab EGFR T790M-Liquid Biopsy | 81235 | 5 |
| LI | NeoLab FLT3 Mutation Analysis-Liquid Biopsy | 81479 | 5 |
| LJ | NeoLab IDH1 Mutation Analysis-Liquid Biopsy | 81120 | 5 |
| LK | NeoLab IDH2 Mutation Analysis-Liquid Biopsy | 81121 | 5 |
| LM | NeoLab inv(16) CBFB-MYH11 Translocation-Liquid Biopsy | 81401 | 5 |
| LN | NeoLab KRAS Mutation Analysis-Liquid Biopsy | 81479 | 5 |
| LO | NeoLab MDS/CMML Profile-Liquid Biopsy | 81450 | 5 |
| LP | NeoLab Myeloid Disorders Profile-Liquid Biopsy | 81450 | 5 |
| LQ | NeoLab NPM1 Mutation Analysis-Liquid Biopsy | 81310 | 5 |
| LR | NeoLab NRAS Mutation Analysis-Liquid biopsy | 81311 | 5 |
| LS | NeoLab PML-RARA Translocation-Liquid Biopsy | 81315 | 5 |
| LU | NeoLab RUNX1-RNX1T1 Translocation-Liquid Biopsy | 81401 | 5 |
| LV | NeoLab Solid Tumor Monitor-Liquid Biopsy | 81445 | 5 |
| Flow Cytometry | |||
| LW | Refrigerate and Hold | No CPT Code Available | 20 |
| LX | Freeze and Hold | No CPT Code Available | 20 |
| Cytogenetics | |||
| LY | Culture and Hold | No CPT Code Available | 20 |
| FISH | |||
| LZ | Direct Harvest and Hold for FISH | No CPT Code Available | 20 |
| Molecular Testing | |||
| MA | Freeze and Hold | No CPT Code Available | 20 |
| MB | Extract Nucleic Acid and Hold | No CPT Code Available | 20 |
South Texas Veterans Healthcare System &"-,Bold"&14SOURCES SOUGHT Specialty Genetic Reference Lab Testing Services
&"-,Bold Italic"Exhibit A 3C25721Q0090 &"-,Bold Italic"Page &P of &N
File details come from the government source that posted it. Updated .